Man Group PLC Acumen Pharmaceuticals, Inc. Transaction History

Man Group PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.14 - $4.01 $175,069 - $328,050	-81,808 Reduced 43.61%	105,777 $255,000
Q1 2024 May 15, 2024	BUY	$2.97 - $4.64 $127,576 - $199,311	42,955 Added 29.7%	187,585 $759,000
Q4 2023 Feb 14, 2024	BUY	$1.86 - $4.48 $269,011 - $647,942	144,630 New	144,630 $555,000
Q1 2023 May 15, 2023	BUY	$3.75 - $6.65 $15,795 - $28,009	4,212 Added 19.56%	25,741 $104,000
Q4 2022 Feb 14, 2023	BUY	$4.81 - $10.17 $103,554 - $218,949	21,529 New	21,529 $116,000

41.8M

57.7K

749K

Ticker ABOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,503,100
Market Cap $72.5M
Description
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.